Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2010
03/31/2010CN101687854A Compounds and compositions as C-KIT and PDGFR kinase inhibitors
03/31/2010CN101687853A Pyrimidine derivatives and compositions as C-KIT and PDGFR kinase inhibitors
03/31/2010CN101687852A Thiazoles and pyrazoles useful as kinase inhibitors
03/31/2010CN101687851A organic compounds
03/31/2010CN101687850A Substituted pyrimidines as adenosine receptor antagonists
03/31/2010CN101687849A crystalline forms of solvated ilaprazole
03/31/2010CN101687848A Solid state forms of racemic ilaprazole
03/31/2010CN101687847A N5-(2-ethoxyethyl)-N3-(2-pyridinyl) -3,5-piperidinedicarboxamide derivatives for use as renin inhibitors
03/31/2010CN101687846A oxime ester photoinitiators
03/31/2010CN101687845A Isothiazole and pyrazole derivatives as fungicides
03/31/2010CN101687844A Imidazole derivatives as CCR2 receptor antagonists
03/31/2010CN101687843A Substituted aromatic heterocyclic compounds as fungicides
03/31/2010CN101687842A modulators of cftr
03/31/2010CN101687841A Benzimidazole derivatives
03/31/2010CN101687840A Benzimidazole amido derivatives as kinase inhibitors
03/31/2010CN101687839A Fungicides phenyl-pyrimdinyl-amino derivatives
03/31/2010CN101687838A Pyrrolo [3, 2-a] pyridine derivatives for inhibiting ksp kinesin activity
03/31/2010CN101687822A Di(arylamino)aryl compound
03/31/2010CN101687821A protein kinase inhibitors and methods for using thereof
03/31/2010CN101687816A Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
03/31/2010CN101687815A a regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles
03/31/2010CN101687808A indazolamide derivatives
03/31/2010CN101687802A Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
03/31/2010CN101687801A Ethers of naphtalene carboxylic acid amides as cancer cure
03/31/2010CN101687789A Novel inhibitors hepatitis c virus replication
03/31/2010CN101684103A Compound with 1,2,4-triazole structure and preparation method and application thereof
03/31/2010CN101684099A Propionic acid derivative of substituted aromatic ring and aromatic heterocycle and preparation method and application thereof
03/31/2010CN101684095A Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/31/2010CN101684091A cannabinoid receptor ligands
03/31/2010CN101684088A Cyanomethyl pyrrole derivative and preparation method and application thereof
03/30/2010US7687643 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction
03/30/2010US7687640 3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzaldehyde; inhibits production of A beta 40 and A beta 42 from amyloid precursor protein ; Alzheimer's disease and Down syndrome
03/30/2010US7687639 Useful as adjuvants to chemotherapy or radiation therapy to treat cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2); 2-[4-(3,4-dichloro-phenoxy)-phenyl]-1H-imidazo[4,5-b]pyridine-5-carboxylic acid amide
03/30/2010US7687638 C-(3-Methyl-5-phenyl-3H-benzoimidazol-4-yl)-methylamine; diabetes, fasting plasma glucose (IFG), metabolic acidosis, ketosis, appetite regulation, obesity, immunosuppressants or cytokine release regulation, autoimmune diseases such as inflammatory bowel disease, multiple sclerosis and arthritis
03/30/2010US7687625 Antidiabetic agents; obesity; controlling appetite
03/30/2010US7687535 Substituted 3-sulfur indoles
03/30/2010US7687533 N-(1-arylpyrazol-4l) sulfonamides and their use as parasiticides
03/30/2010US7687532 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of I.A. rheumatoid arthritis
03/30/2010US7687525 e.g. N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; anticarcinogenic, antitumor agents; hematologic malignancy and a solid carcinoma; autoimmune disease, skin disorders;
03/30/2010US7687518 4-Tetrazolyl-4-phenylpiperidine compounds for prophylaxis and therapy of pain or diarrhea in an animal
03/30/2010US7687510 Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes
03/30/2010US7687508 Cyclic derivatives as modulators of chemokine receptor activity
03/30/2010US7687504 1-[3-[2-[2-cyano-(S)-pyrrolidin-1-yl]-2-oxo-ethylamino]-1-oxo-propyl]-4-[bis-(4-fluorophenyl)methyl]piperazine; inhibiting dipeptidyl peptidase IV or for treating Type II diabetes
03/30/2010US7687503 2-(methylamino)-2-oxoethyl 4-{5-[3-(trifluoromethyl)-phenyl]-2-pyridyl}-1-piperazinecarboxylate, for example; enzyme inhibitors of fatty acid amide hydrolases; treatment of pain, eating disorders, neurological and psychiatric pathologies, among other disorders
03/30/2010US7687502 Substituted quinazoline or pyridopyrimidine derivative
03/30/2010US7687498 N-(Arylidene)morpholinylpyridinylhydrazine derivatives, e.g., N-{4-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-6-morpholin-4-yl-pyridin-2-yl}-N'-(3-methyl-benzylidene)-hydrazine, are used for treating interleukin-12 overproduction-related disorders including inflammatory diseases
03/30/2010US7687495 {(2S,4R,5R)-4-(4-Methoxy-phenyl)-5-[4-(3-methoxy-propyl)-3,4-dihydro-2H-benzo[1,4]oxazin-6-ylmethoxy]-piperidin-2-yl}-methanol; renin enzyme inhibitor; hypertensive agent; heart/kidney failure; glaucoma cardiac infarction; restenosis; stroke; reduces forming of angiotensin I, therefore angiotensin II als
03/30/2010US7687067 combating phytopathogenic fungi
03/30/2010CA2457444C 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
03/30/2010CA2452920C Benzo [g] quinoline derivatives for treating glaucoma and myopia
03/30/2010CA2442245C 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity
03/30/2010CA2389306C Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
03/25/2010WO2010033977A2 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
03/25/2010WO2010033168A2 Amide compounds, compositions and uses thereof
03/25/2010WO2010032874A1 Composition for agricultural use
03/25/2010WO2010032856A1 Nitrogen-containing heterocyclic compound and use of same
03/25/2010WO2010032731A1 Benzimidazole compound in crystal form and salt thereof
03/25/2010WO2010031852A1 Novel estrogen receptor ligands
03/25/2010WO2010031713A1 Substituted pyrrolidine-2-carboxamides
03/25/2010WO2010031589A1 Small molecule bradykinin b2 receptor modulators
03/25/2010WO2010031265A1 Pharmaceutical composition for the treatment of proliferative diseases
03/25/2010WO2009141533A3 Pyrrole derivatives, preparation of same and therapeutic application thereof as cannabinoid cb1 receptor antagonists
03/25/2010US20100076197 Process for rimonabant
03/25/2010US20100076189 Process for the preparation of imatinib and intermediates thereof
03/25/2010US20100076187 Fast dissociating dopamine 2 receptor antagonists
03/25/2010US20100076051 Isoindolinone kinase inhibitors
03/25/2010US20100076029 Compounds Which Selectively Modulate The CB2 Receptor
03/25/2010US20100076028 Design and Synthesis of Novel Antimicrobials
03/25/2010US20100076027 Indazole or 4,5,6,7-tetrahydro-indazole derivatives
03/25/2010US20100076026 3-amino-indazole or 3-amino-4,5,6,7-tetrahydro-indazole derivatives
03/25/2010US20100076025 Process for solvent removal from omeprazole salts
03/25/2010US20100076023 Amorphous solid composition containing a pyrazole-3-carboxamide in amorphous form and stabilising carriers
03/25/2010US20100076022 Novel polymorphs of rimonabant
03/25/2010US20100076021 Organic Compounds
03/25/2010US20100076020 Quinolynylmethylimidizoles as therapeutic agents
03/25/2010US20100076015 Aminopyridine Derivatives
03/25/2010US20100076014 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
03/25/2010US20100076004 Bicyclic spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
03/25/2010US20100075993 Small molecule inhibitors against west nile virus replication
03/25/2010US20100075990 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
03/25/2010US20100075989 Novel Compounds Having Selective Inhibiting Effect at GSK3
03/25/2010US20100075988 Tetrahydroquinazoline compounds and their use in preparing medicaments for treating and preventing virosis
03/25/2010US20100075987 Acyl bipiperidinyl compounds, compositions containing such compounds and methods of treatment
03/25/2010US20100075986 Oxophenyl-Cyclohexyl-Propanolamine Derivatives, Production And Use Thereof In Therapeutics
03/25/2010US20100075981 such as N-{trans-4-[2-(4-Isoxazolo[4,5-c]pyridin-3-yl-piperazin-1-yl)-ethyl]-cyclohexyl}-acetamide, used for the therapeutic and/or prophylactic treatment of cognitive disorders, psychological disorders, drug abuse and drug dependence
03/25/2010US20100075980 Phenylacetamides being FLT3 Inhibitors
03/25/2010US20100075979 Pyridinylpiperazin derivatives useful as modulators of dopamine d3 receptors
03/25/2010US20100075978 Sulfonamide derivatives as bradykinin antagonists
03/25/2010US20100075976 Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists
03/25/2010US20100075971 Substituted pyridine derivatives useful in the treatment of cancer and other disorders
03/25/2010US20100075970 Inhibitors of akt activity
03/25/2010US20100075968 Imidazolidine Carboxamide Derivatives as P2X7 Modulators
03/25/2010US20100075967 Pyrimidine derivatives for treatment of hyperproliferative disorders
03/25/2010US20100075966 Substituted Dihydroimidazoles and their Use in the Treatment of Tumors
03/25/2010US20100075964 Imidazole based lxr modulators
03/25/2010US20100075962 Indol derivatives, the method for preparing thereof and composition for the prevention and treatment of metabolic disorder containing the same as an active ingredient
03/25/2010US20100075956 N-(1-arylpyrazol-4l)sulfonamides and their use as parasiticides
03/25/2010US20100075953 Substituted piperazines, (1,4) diazepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
03/25/2010US20100075949 Novel pyrrolidin-2-ones
03/25/2010US20100075948 Substituted Pyrrolidine-2-Carboxamides
1 ... 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 ... 1080